Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

0.9908
Delayed Data
As of Apr 27
 -0.0292 / -2.86%
Today’s Change
0.82
Today|||52-Week Range
2.57
-24.94%
Year-to-Date
No recent news for Repros Therapeutics Inc.

Today’s Trading

Previous close1.02
Today’s open1.04
Day’s range0.95 - 1.04
Volume96,479
Average volume (3 months)136,382
Market cap$27.2M
Dividend yield--
Data as of 3:59pm ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)+41.67%
Earnings growth (this year)-8.57%
Earnings growth (next 5 years)+27.95%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.32

Competitors

 Today’s
change
Today’s
% change
CATBCatabasis Pharmaceut...-0.02-1.38%
CAPNCapnia Inc-0.00-0.34%
HTBXHeat Biologics Inc-0.01-1.27%
PRANPrana Biotechnology ...+0.13+4.50%
Data as of 4:14pm ET, 04/27/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$0.00
Annual profit (last year)-$17.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Larry M. Dillaha
CFO, Secretary &
Chief Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts